xista science ventures

Xista Ventures is a venture capital firm that focuses on transforming groundbreaking scientific discoveries into commercial ventures. With a strong emphasis on biotech, medtech, and deep tech, Xista operates out of Austria, leveraging its close ties to the Institute of Science and Technology Austria (ISTA). Their portfolio includes innovative companies like Prewave, which uses AI to predict supply chain risks, and VALANX Biotech, known for its precise protein conjugation technology. Xista primarily invests in early-stage startups, guiding them through critical processes such as university agreements, corporate partnerships, and securing funding. Their focus is on startups with a clear impact on human and planetary health. Typical investment stages range from pre-seed to Series A, with Xista often leading rounds. Their companies have raised over €200 million in grants and equity. Founders benefit from continuous support, from due diligence to strategic scaling, with Xista emphasizing long-term partnership and success.